<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-KSB
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended September 30, 1999
Commission file number 33-17387
ALLIANCE HEALTH, INC.
(Exact name of registrant as specified in its charter)
Delaware 75-219377
(State or other jurisdiction of (I.R.S. Employer I.D.#)
incorporation or organization)
421 E. Airport Freeway, Irving, Texas 75062
(Address of principal executive office) (Zip Code)
Issuer's telephone number, including area code (972)-255-5533
Securities registered under Section 12(b) of the Exchange Act:
Name of each exchange on
Title of each class which registered
- ---------------------------------------------------------------------------
Securities registered under Section 12(g) of the Exchange Act:
Common Stock, par value $0.01
___________________________________________________________________________
(Title of class)
___________________________________________________________________________
(Title of class)
Check whether the issuer (1) filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
past 12 months (or for shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes X No
State issuer's revenues for its most recent fiscal year $3,840,955.
State the aggregate market value of the voting stock held by non-
affiliates computed by reference to the price at which the stock was sold,
or the average bid and asked prices of such stock, as of a specified date
within the past 60 days. No market for common stock.
Check whether the issuer has filed all documents and reports required
to be filed by Section 12, 13, or 15(d) of the Exchange Act after the
distribution of securities under a plan confirmed by a court. Yes X
No
State the number of shares outstanding of each of the issuer's
classes of common equity, as of the latest practicable date. 3,590,000
<PAGE>
PART I.
Item 1. Description of Business
Alliance Health, Inc. ("Company") was incorporated on September 4,
1987. It had no business activity until July 1989 at which time it began
to operate one clinic in Dallas, Texas, which it closed the same year.
On May 12, 1995, the Company acquired from K Clinics, P.A. ("K
Clinics"), the marketing division of K Clinics. The marketing division
will continue the contract to perform advertising and marketing services
for S. J. Kechejian, M.D., P.A. and Metroplex Specialties, P.A. medical
facilities in the Dallas/Ft. Worth Metroplex.
Metroplex Specialties, P.A. is one of the "affiliates" of the
Company. On October 23, 1995 the Company began leasing an MRI it purchased
and installed at 200 W. Colorado Blvd., Dallas, Texas to Metroplex
Specialties, P.A. for $300 per scan. In the year 1999 revenue was
$1,033,500 as compared to 1998 revenue of $887,100. The Hitachi MRI
purchased by the Company located at 1218 S. Main Street, Ft. Worth, Texas,
is being leased at the same rate of $300 per scan and generated income in
1999 of $392,400 as compared to 1998 of $153,600.
In January 1999, the Company purchased a Mobile Hitachi MRI for
$825,000 and in May 1999 a tractor for $97,787 to move the mobile unit.
The mobile unit is leased to Metroplex Specialties at the rate of $300 per
scan and has generated $93,600 from May 1999 through September 1999.
The Company purchased a CT Scanner in September, 1998 for $45,869
which is leased to Aldine Medical Associates for $125 per scan. In the 9
month period from January 1999 to September 1999 $13,125 of revenue was
generated from this lease.
Alliance Health has the experience through its association with K
Clinics in the Dallas/Fort Worth area to offer the services of a Management
Service Organization (MSO). K Clinic has developed innovative marketing,
advertising and administrative services over the past ten years in
conjunction with S. J. Kechejian, M.D., P.A. In May 1995 the advertising
division of K Clinics was sold to Alliance Health, Inc. The further
development of the MSO and offering of additional administrative and
specialty services to physicians and medical groups have been developed and
implemented.
Item 2. Description of Property
None.
Item 3. Legal Proceedings
The Company is not a party to any pending legal proceedings.
Item 4. Submission of Matters to a Vote of Security Holders
No matters were submitted to a vote of security holders during the
fourth quarter of the fiscal year covered by this report.
-2-
<PAGE>
PART II
Item 5. Market for the Registrant's Common Stock
and Related Shareholder Matters
On September 30, 1999 the approximate number of holders of record of
the Company common stock was 306. The Company's common stock has no
established trading market.
The Company has never paid any cash dividends on the common stock and
does not expect to do so in the foreseeable future. However, the Company
declared a four for one stock split of its outstanding shares of common
stock effective the close of business December 24, 1999.
Item 6. Management's Discussion and Analysis or Plan of Operation
Prior to May 1995, the Company had no operating business since June
1990. On May 12, 1995, an 8-K was filed regarding the acquisition of the
Marketing Division of K Clinics which included $285,879 in cash in exchange
for one million two hundred thousand (1,200,000) shares of common stock of
Alliance Health, Inc. (the "Company"). In July 1995, the shares were
transferred to Sarkis J. Kechejian. K Clinics is wholly owned by Sarkis
J. Kechejian, M.D. who is also the principal shareholder of the Company.
The Company's primary source of income during the year was
advertising income. An increase of forty percent (40%) was realized in
1999 as compared to 1998. This was due to fees from Aldine Medical
Associates, an affiliate, and an increase in the number of facilities at
S. J. Kechejian, M.D., P.A. and an increase in the advertising fees charged
to PT/OT Rehab Centers. Other marketing income was generated from Metro
Pharmacy, Inc. and Metroplex Specialties, Inc.
The Company also realized a considerable increase in fees from
Metroplex Specialties, P.A. from the MRI lease. An increase of fifty eight
percent (58%) was realized in 1999 as compared to 1998, primarily due to
the new mobile MRI lease and increased scans at the other units. The
revenue from Metroplex Specialties, P.A. is on a per scan basis and is
expected to continue at roughly $125,000 per month during the next fiscal
year.
During the past 2 years the Company has continued to develop its
management and administrative services. These services have been primarily
to Aldine Medical Associates and its group of clinics and specialties in
East Texas. The Company expects revenues to increase over the next year.
Expenses in 1999 increased forty five percent (45%) over 1998,
principally due to an increase in operations. General and administrative
expenses increased eighty five percent (85%) during the 1999 year,
principally due to increases in administrative fees, rent and maintenance.
Aldine Medical Associates ("Aldine"), an affiliate, will lease its
furniture, fixtures and equipment from the Company at cost plus ten percent
(10%). The majority of the furniture, fixtures and equipment to be leased
to Aldine for the Tyler clinic is from the Aldine Medical Clinic of
Houston (now closed) and any additional furniture, fixtures and equipment
required will be purchased by the Company and leased at the same rate.
-3-
<PAGE>
Liquidity and Financial Resources
The Company had $592,547 in cash at September 30, 1999.
The Company has an agreement with Metroplex Specialties, P.A. for the
lease of three MRIs at $300/per scan. It is expected this lease will
continue to produce revenues of approximately $125,000 per month.
The facility in Tyler, Texas purchased 1998 is primarily being leased
to Aldine Medical Associates. The facility will initially house a physical
therapy center and an imaging center and is being leased for $2,500 per
month. One office in the facility is leased to Texas Wildlife Damage
Management Service for $323 per month.
The Company has loaned Aldine $271,506 in start-up and administrative
costs. The loan was to be paid back during the year ended September 30,
1999 with an interest rate of 10%. As of September 30, 1999, the
outstanding balance due on the loan was $176,137. The loan has been
extended at the same interest rate for an additional year.
The Company's primary source of income continues to be from fees
generated by the marketing and advertising services for S. J. Kechejian,
M.D., P.A., Aldine Medical Associates, Metroplex Specialties, P.A. and
Metro Pharmacy, Inc. It is anticipated the revenue for marketing services
will increase in the next year as S. J. Kechejian, M.D., P.A. and Aldine
Medical Associates are expected to add additional clinic locations thus
increasing the need for additional marketing services.
The Company has long term debt outstanding at year end of $195,965,
incurred from the purchase of a building at 232 W. Tenth, Dallas, Texas for
$230,000. At this time the company is planning on leasing this building
for a medical facility in the year 2000. Income from the marketing
division, lease of the MRIs and CT Fees are expected to produce sufficient
cash flow to cover all operating and administrative expenses.
Year 2000. The company currently believes that it does not have any
significant exposure to uncertainties nor material anticipated costs with
regard to Year 2000 issues. Current systems and any anticipated upgrades
are 2000 compliant.
Item 7. Financial Statements
Financial statements in response to Item 7 are presented on pages F-1
through F-11.
-4-
<PAGE>
ALLIANCE HEALTH, INC.
INDEX TO AUDITED FINANCIAL STATEMENTS
Page
Independent Auditors' Report . . . . . . . . . . . . . . . . . . . .F-2
Balance Sheets at September 30, 1999 and 1998. . . . . . . . . . . .F-3
Statements of Income for the Years Ended
September 30, 1999 and 1998 . . . . . . . . . . . . . . . . . . .F-4
Statements of Changes in Stockholders' Equity
for the Years Ended September 30, 1999 and 1998 . . . . . . . . .F-5
Statements of Cash Flows for the Years Ended
September 30, 1999 and 1998 . . . . . . . . . . . . . . . . . . .F-6
Notes to Financial Statements. . . . . . . . . . . . . . . . . . . .F-7
F-1
<PAGE>
INDEPENDENT AUDITORS' REPORT
Board of Directors
Alliance Health, Inc.
We have audited the accompanying balance sheets of Alliance Health,
Inc. as of September 30, 1999 and 1998, and the related statements of
income, changes in stockholders' equity and cash flows for the years
then ended. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on
these financial statements based on our audits.
We conducted our audits in accordance with generally accepted
auditing standards. Those standards require that we plan and perform
the audits to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above present
fairly, in all material respects, the financial position of Alliance
Health, Inc. as of September 30, 1999 and 1998, and the results of
its operations and its cash flows for the years then ended in
conformity with generally accepted accounting principles.
Jackson & Rhodes P.C.
Dallas, Texas
November 10, 1999
F-2
<PAGE>
ALLIANCE HEALTH, INC.
BALANCE SHEETS
September 30, 1999 and 1998
ASSETS
<TABLE>
<CAPTION>
1999 1998
<S> <C> <C>
Current assets:
Cash $ 592,547 $ 739,596
Accounts receivable - affiliates (Note 7) 177,961 64,413
Other assets 45,587 12,134
Income taxes receivable 121,320 -
Total current assets 937,415 816,143
Property and equipment (Notes 3) 3,824,721 2,451,752
Less accumulated depreciation (1,027,307) (591,577)
2,797,414 1,860,175
$3,734,829 $2,676,318
LIABILITIES AND STOCKHOLDERS' EQUITY
<CAPTION>
<S> <C> <C>
Current liabilities:
Accounts payable - trade $ 57,558 $ 52,825
Accrued liabilities 26,350 21,116
Current portion of long-term debt 4,035 -
Income taxes payable - 249,889
------- -------
Total current liabilities 87,943 323,830
Long-term debt, less current maturities (Note 4) 195,965 -
Deferred income taxes 69,502 34,532
------- -------
265,467 34,532
------- -------
Total liabilities 353,410 358,362
Commitments and contingencies (Note 6) - -
Stockholders' equity:
Preferred stock, $.01 par, 100,000 shares
authorized, none issued - -
Common stock, $.01 par, 20,000,000 shares
authorized, 3,590,000 shares issued
and outstanding 35,900 35,900
Paid-in capital 831,166 831,166
Retained earnings 2,514,353 1,450,890
--------- ---------
Total stockholders' equity 3,381,419 2,317,956
--------- ---------
$3,734,829 $2,676,318
</TABLE>
See accompanying notes to financial statements.
F-3
<PAGE>
ALLIANCE HEALTH, INC.
STATEMENTS OF INCOME
Years Ended September 30, 1999 and 1998
<TABLE>
<CAPTION>
1999 1998
--------- ----------
<S> <C> <C>
Revenues:
Advertising income from affiliate
(Note 7) $ 2,118,125 $ 1,520,000
MRI income from affiliate (Note 7) 1,682,925 1,070,445
Interest 39,905 26,753
--------- ---------
3,840,955 2,617,198
Expenses:
Advertising 868,770 649,672
Salaries and employee benefits 430,995 396,172
Depreciation 435,730 249,893
General and administrative 624,327 338,939
--------- ---------
2,359,822 1,634,676
Operating income 1,481,133 982,522
Other income 154,288 26,948
--------- ---------
Income before taxes 1,635,421 1,009,470
Income taxes (Note 5) 571,958 361,856
Net income $ 1,063,463 $ 647,614
Basic earnings per common share $ 0.30 $ 0.18
Weighted average number of
common shares outstanding 3,590,000 3,590,000
</TABLE>
See accompanying notes to financial statements.
F-4
<PAGE>
ALLIANCE HEALTH, INC.
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
Years Ended September 30, 1999 and 1998
<TABLE>
<CAPTION>
Common Stock Additional
Par Paid-In Retained
Shares Value Capital Earnings Total
--------- ------- --------- --------- ---------
<S> <C> <C> <C> <C> <C>
Balance, 9-30-97 3,590,000 $35,900 $831,166 $ 803,276 $1,670,342
Net Income - - - 647,614 647,614
--------- ------ ------- --------- ---------
Balance, 9-30-98 3,590,000 35,900 831,166 1,450,890 2,317,956
Net Income - - - 1,063,463 1,063,463
--------- ------ ------- --------- ---------
Balance, 9-30-99 3,590,000 $35,900 $831,166 $2,514,353 $3,381,419
</TABLE>
See accompanying notes to financial statements.
F-5
ALLIANCE HEALTH, INC.
STATEMENTS OF CASH FLOWS
Years Ended September 30, 1999 and 1998
<TABLE>
<CAPTION>
1999 1998
--------- ----------
<S> <C> <C>
Cash flows from operating activities:
Net income $1,063,463 $ 647,614
Adjustments to reconcile net income
to net cash provided by operating
activities:
Depreciation 435,730 249,894
Deferred income taxes 34,970 40,518
Changes in assets and liabilities:
Accounts receivable-affiliates 26,667 59,390
Other assets (33,453) (2,592)
Federal income taxes payable (371,209) (37,341)
Accounts payable 4,733 (16,934)
Accrued liabilities 5,234 21,116
Net cash provided by --------- ---------
operating activities 1,166,135 961,665
--------- ---------
Cash flows from investing activities:
Purchase of equipment (1,372,969) (1,217,330)
--------- ---------
Cash flows from financing activities:
Accounts receivable-affiliates (140,215) 54,545
Proceeds from long-term debt 200,000 -
Net cash provided by financing --------- ---------
activities 59,785 54,545
Net decrease in cash (147,049) (201,120)
Cash at beginning of year 739,596 940,716
--------- ---------
Cash at end of year $ 592,547 $ 739,596
--------- ---------
Income taxes paid $1,257,487 $ 358,678
--------- ---------
</TABLE>
See accompanying notes to financial statements.
F-6
<PAGE>
ALLIANCE HEALTH, INC.
Notes to Financial Statements
September 30, 1999 and 1998
1. Organization
Alliance Health, Inc. (the "Company") was incorporated in
Delaware on September 4, 1987. On May 12, 1995, the Company
acquired the advertising division (the "Division") of K Clinics,
P.A. ("K Clinics"). The Company currently offers advertising
and management services to medical clinics of affiliated
companies (see Note 7).
2. Summary of Significant Accounting Policies
Use of Estimates and Assumptions
Preparation of the Company's financial statements in conformity
with generally accepted accounting principles requires
management to make estimates and assumptions that affect certain
reported amounts and disclosures. Accordingly, actual results
could differ from those estimates.
Statement of Cash Flows
For statement of cash flow purposes, the Company considers
short-term investments with original maturities of three months
or less to be cash equivalents.
Property and Equipment
Property and equipment are stated at cost. Cost of property
renewals and betterments are capitalized; cost of property
maintenance and repairs are charged against operations as
incurred.
Depreciation is computed using the straight-line method over the
estimated useful lives of the individual assets as follows:
Equipment 7 years
Furniture and fixtures 4 years
Leasehold improvements 5 years
Income Taxes
The Company accounts for income taxes in accordance with
Statement of Financial Accounting Standards No. 109, "Accounting
for Income Taxes" ("SFAS 109"). SFAS 109 utilizes the asset and
liability method of computing deferred income taxes. The
objective of the asset and liability method is to establish
deferred tax assets and liabilities for the temporary
differences between the financial reporting basis and the tax
basis of the Company's assets and liabilities at enacted tax
rates expected to be in effect when such amounts are realized or
settled.
F-7
<PAGE>
ALLIANCE HEALTH, INC.
Notes to Financial Statements
2. Summary of Significant Accounting Policies (Continued)
Earnings Per Common Share
In March 1997, the Financial Accounting Standards Board issued
Statement of Financial Accounting Standards No. 128, Earnings Per
Share ("SFAS 128"). SFAS 128 provides a different method of
calculating earnings per share than was formerly used in APB Opinion
15. SFAS 128 provides for the calculation of basic and diluted
earnings per share. Basic earnings per share includes no dilution and
is computed by dividing income available to common stockholders by the
weighted average number of common shares outstanding for the period.
Dilutive earnings per share reflects the potential dilution of
securities that could share in the earnings of the Company. The
Company was required to adopt this standard in the fourth quarter of
calendar 1997. Because the Company has no potential dilutive
securities outstanding, the accompanying presentation is only of basic
earnings per share.
3. Property and Equipment
Property and equipment consisted of the following at September 30:
1999 1998
Buildings $ 530,836 $ 300,836
Equipment (principally magnetic
resonance imaging) 2,814,897 1,795,006
Leasehold improvements 439,988 316,910
Furniture and fixtures 39,000 39,000
--------- ---------
$3,824,721 $2,451,752
4. Long-term Debt
The Company borrowed $200,000 for the addition of a building during
1998. The note requires monthly payments of $1,642 per month,
including interest at 8% and matures on October 1, 2002. Minimum
principal payments are as follows:
For the Year Ended
September 30: Amount
------------------ ---------
2000 $ 4,035
2001 4,680
2002 4,620
2003 186,665
F-8
<PAGE>
ALLIANCE HEALTH, INC.
Notes to Financial Statements
5. Income Taxes
Following is a reconciliation between reported income taxes and the
amount computed by applying the statutory federal income tax rates to
pre-tax accounting income for the years ended September 30:
1999 1998
------- -------
Expected provision for federal
income taxes $556,000 $343,200
State income taxes 63,550 51,500
Other (47,592) (32,844)
------- -------
$571,958 $361,856
Income taxes were as follows for the years ended September 30:
1999 1998
------- -------
Current $536,988 $321,338
Deferred 34,970 40,518
------- -------
$571,958 $361,856
The components of the deferred tax asset (liability) are as follows at
September 30:
1999 1998
------- -------
Depreciation $ (74,502) $(64,458)
Alternative minimum tax 25,522 25,522
Cash basis (20,522) 4,404
------- -------
$ (69,502) $ 34,532)
6. Commitments and Contingencies
Concentration of Credit Risk
The Company invests its cash and certificates of deposit primarily in
deposits with major banks. Certain deposits, at times, are in excess
of federally insured limits. The Company has not incurred losses
related to its cash.
Uncertainty Due to the Year 2000 Issue
The Year 2000 issue arises because many computerized systems use two
digits rather than four to identify a year. Date-sensitive systems may
recognize the year 2000 as 1900 or some other date, resulting in errors
when information using year 2000 dates is processed. In addition,
similar problems may arise in some systems which use certain dates in
1999 to represent something other than a date. The effects of the Year
2000 issue may be experienced before, on, or after January 1, 2000 and,
if not addressed, the impact on operations and financial reporting may
range from minor errors to significant systems failure which could
impact the Company's ability to conduct normal business operations. It
is not possible to be certain that all aspects of the Year 2000 issue
affecting the Company will be fully resolved.
F-9
<PAGE>
7. Related Party Transactions
All of the Company's advertising income and MRI income was for services
rendered to various affiliated companies owned by the Company's major
stockholder. The Company has loaned an affiliate $271,506 to fund
start-up costs during fiscal year 1999. The affiliate is to pay the
borrowings back with 10% interest.
The Company leases its office space and equipment on a month-to-month
basis from S. J. Kechejian, M.D., P.A., an affiliated company. The
amounts paid in 1999 and 1998 were $34,500 and $30,635, respectively.
The company leases its Dallas MRI facility on a month to month basis
from Arax Limited Partnership for which it paid $26,250 for fiscal year
ended September 30, 1999, and $15,365 for fiscal year ended 1998. The
Ft. Worth MRI facility is leased on a month to month basis from SK
Properties for which it paid $26,250 for fiscal year ended September
30, 1999, and $8,750 for fiscal year ended September 30, 1998.
The Company also paid K Clinics' fees amounting to $164,000 during the
year ended September 30, 1999.
8. Accounting Developments
SFAS 129
Statement of Financial Accounting Standards No. 129, "Disclosure of
Information About Capital Structure" ("SFAS 129"), effective for
periods ending after December 15, 1997, establishes standards for
disclosing information about an entity's capital structure. SFAS 129
requires disclosure of the pertinent rights and privileges of various
securities outstanding (stock, options, warrants, preferred stock, debt
and participating rights) including dividend and liquidation
preferences, participant rights, call prices and dates, conversion or
exercise prices and redemption requirements. Adoption of SFAS 129 has
had no effect on the Company as it currently discloses the information
specified.
SFAS 130
Statement of Financial Accounting Standards No. 130, "Reporting
Comprehensive Income" ("SFAS 130"), establishes standards for reporting
and display of comprehensive income, its components and accumulated
balances. Comprehensive income is defined to include all changes in
equity except those resulting from investments by owners and
distributions to owners. Among other disclosures, SFAS 130 requires
that all items that are required to be recognized under current
accounting standards as components of comprehensive income be reported
in a financial statement that is displayed with the same prominence as
other financial statements. Results of operations and financial
position are unaffected by implementation of this new standard.
F-10
<PAGE>
8. Accounting Developments (Continued)
SFAS 131
SFAS 131, "Disclosure About Segments of a Business Enterprise,"
establishes standards for the way that public enterprises report
information about operating segments in annual financial statements and
requires reporting of selected information about operating segments in
interim financial statements issued to the public. It also establishes
standards for disclosures regarding products and services, geographic
areas and major customers. SFAS 131 defines operating segments as
components of an enterprise about which separate financial information
is available that is evaluated regularly by the chief operating
decision maker in deciding how to allocate resources and in assessing
performance. This accounting pronouncement will not have an effect on
the Company's financial statements, since the Company only operates in
one segment of business, the offering of advertising and management
services to medical clinics.
SFAS 132
Statement of Financial Accounting Standards (SFAS) 132, "Employers'
Disclosure about Pensions and Other Postretirement Benefits," revises
standards for disclosures regarding pensions and other postretirement
benefits. It also requires additional information on changes in the
benefit obligations and fair values of plan assets that will facilitate
financial analysis. This statement does not change the measurement or
recognition of the pension and other postretirement plans. The
financial statements are unaffected by implementation of this new
standard.
F-11
<PAGE>
Item 8. Changes in and Disagreements with Accountants on
Accounting and Financial Disclosure
None.
Part III
Item 9. Directors, Executive Officers, Promoters and Control
Persons, Compliance with Section 16(A) of the Exchange Act
The executive officers and directors of Alliance Health, Inc. are
identified in the following table. Each has held the indicated
positions with Alliance Health, Inc. since May 19, 1995, and will serve
in these offices until their successors are elected and qualified.
NAME AGE POSITION
Sarkis J. Kechejian 61 President, Treasurer
and Chairman of the Board
Sharilyn J. Bruntz Wilson 49 Vice President and Secretary
Richard C. Schneck 49 Chief Operating Officer
Kenneth Guest 60 Director
James Kenney 58 Director
George Nicolaou, M.D. 78 Director
Mac Martirossian 45 Director
Dr. Kechejian is also president and sole owner of S. J. Kechejian,
M.D., P.A., Metro Pharmacy, Inc., Metroplex Specialties, P.A. and
Aldine Medical Associates, which consists of two clinics, one PT/OT
Center and one cat scan imaging center treating patients injured on the
job or in auto accidents.
Ms. Wilson is the Chief Financial Officer of S. J. Kechejian,
M.D., P.A. and was Secretary/Treasurer of K Med Centers, Inc. from
January, 1987 until December, 1991. Prior to that time, for over five
years, she was a Legal Assistant with several law firms.
Mr. Guest is an attorney who has been practicing in the Dallas area
since 1965. He is with the law firm of Ken Guest and Associates. He
has investments in several manufacturing and retail businesses.
-5-
<PAGE>
James W. Kenney has been a Director since September, 1992. He is
currently associated with San Jacinto Securities, Inc. as Executive
Vice President. From February, 1992 to June, 1993 he served as Vice
President of Investments for Renaissance Capital Group, Inc. From
October, 1989 to February, 1992 he served as Senior Vice President,
Director of Trading and Sales for Capital Institutional Services. From
February, 1987 to October, 1989, he served as Senior Vice President for
retail sales for Rauscher Pierce Refsnes, Inc. Mr. Kenney received a
BA degree in economics from the University of Colorado in Boulder,
Colorado. Mr. Kenney also currently serves on the Board of Directors
of the following companies: Industrial Holdings, Inc., Scientific
Measurement Systems and Antenna Products, Inc.
Dr. Nicolaou is a retired physician. He has extensive business
experience doing consulting work.
Mac Martirossian has been a Director since May, 1996. He is
currently Senior Vice President of Business Development for Howard
Schultz & Associates. From April 1989 to August 1995, he served in
various Executive Management positions at AMRE, Inc., with his last
position as Vice President-Operations.
Richard Schneck is Chief Operating Officer of Alliance Health, Inc.
He joined Alliance in February, 1997. Prior to that time he was an
Executive Manager in HMO operations, as well as Hospital Financial and
Administrative operations. Mr. Schneck has over 20 years of health
care management experience.
Item 10. Executive Compensation
Cash Compensation
For the fiscal year ended September 30, 1999, Dr. Kechejian received
no cash remuneration. Ms. Wilson received a salary of $67,242 and Mr.
Schneck received a salary of $166,500 for the year ended September 30,
1999.
Compensation of Directors
Directors received $500 for each of the three (3) Board of
Director's meetings attended.
Item 11. Security Ownership of Certain Beneficial Owners and Managers
The following information is submitted as of September 30, 1999
with respect to the Company's voting securities owned beneficially by
each person known to the Company who owns more than 5% of the Common
Stock of the Company, this being the only class of voting securities
now outstanding and by all directors and officers of the Company
individually and as a group.
-6-
<PAGE>
Name and Address of Amount Bene- Approximate
Beneficial Owner ficially owned Percent of
Class
- ------------------------ -------------- -----------
Sarkis J. Kechejian, M.D. 2,809,518 78%
421 E. Airport Freeway
Irving, Texas 75062
Nishan J. Kechejian, M.D. 450,000 12.5%
824 Oak St.
Brockton, MA 02401
Item 12. Certain Relationships and Related Transactions
As set forth in the Company's financial statements contained in this
report, all of the Company's advertising income and MRI income was for
services rendered to affiliated companies. The Company's primary
customers are S. J. Kechejian, M.D., P.A., Aldine Medical Associates
and Metroplex Specialties, P.A., all professional corporations wholly
owned by S. J. Kechejian, M.D. These companies provide diagnostic and
therapeutic medical services to patients suffering from soft tissue
injuries generally incurred in automobile or job related accidents.
Dr. Kechejian owns, directly or indirectly, 2,809,518 shares of Common
Stock of the Company (78% of the outstanding shares).
Furthermore, the Company's office facilities are located in the same
office building owned by a company owned by Dr. Kechejian. The Company
leases its office space and equipment on a month to month basis from S.
J. Kechejian, M.D., P.A. for which it paid $34,500 for fiscal year
ended September 30, 1999 and $30,635 for fiscal year ended September
30, 1998. The company leases its Dallas MRI facility on a month to
month basis from Arax Limited Partnership for which it paid $26,250 for
fiscal year ended September 30, 1999, and $15,365 for fiscal year ended
1998. The Ft. Worth MRI facility is leased on a month to month basis
from SK Properties for which it paid $26,250 for fiscal year ended
September 30, 1999, and $8,750 for fiscal year ended September 30,
1998.
PART IV.
Item 13. Exhibits and Reports on Form 8-K
a. Exhibit 27, Financial Data Schedule
-7-
<PAGE>
SIGNATURES
In accordance with Section 13 or 15(d) of the Exchange Act, the
registrant caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ALLIANCE HEALTH, INC.
DATED: December 30, 1999 By:
----------------------------
Sarkis J. Kechejian, M.D.
Chairman of the Board,
President and Treasurer
In accordance with the Exchange Act, this report has been signed
below by the following persons on behalf of the registrant and in the
capacities and on the dates indicated.
DATED: December 30, 1999 _________________________
Sarkis J. Kechejian, M.D.
Chairman of the Board and
President and Treasurer
DATED: December 30, 1999 __________________________
James Kenney
Director
DATED: December 30, 1999 __________________________
George Nicolaou, M.D.
Director
DATED: December 30, 1999 __________________________
Kenneth Guest
Director
DATED: December 30, 1999 __________________________
Mac Martirossian
Director
-8-
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C> <C>
<PERIOD-TYPE> 12-MOS 12-MOS
<FISCAL-YEAR-END> SEP-30-1998 SEP-30-1999
<PERIOD-START> OCT-01-1998 OCT-01-1997
<PERIOD-END> SEP-30-1999 SEP-30-1998
<CASH> 592,547 739,596
<SECURITIES> 0 0
<RECEIVABLES> 344,868 67,438
<ALLOWANCES> 0 0
<INVENTORY> 0 0
<CURRENT-ASSETS> 937,415 807,034
<PP&E> 3,824,721 2,463,887
<DEPRECIATION> (1,027,307) (591,576)
<TOTAL-ASSETS> 3,734,829 2,679,345
<CURRENT-LIABILITIES> 232,488 285,697
<BONDS> 0 0
0 0
0 0
<COMMON> 35,900 35,900
<OTHER-SE> 3,698,929 2,357,748
<TOTAL-LIABILITY-AND-EQUITY> 3,734,829 2,679,345
<SALES> 0 0
<TOTAL-REVENUES> 3,995,243 2,644,147
<CGS> 0 0
<TOTAL-COSTS> 0 0
<OTHER-EXPENSES> 2,359,822 1,634,676
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 0 0
<INCOME-PRETAX> 1,635,421 1,009,471
<INCOME-TAX> 571,958 286,165
<INCOME-CONTINUING> 0 0
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> 1,063,463 723,306
<EPS-BASIC> 0 0
<EPS-DILUTED> 0 0
</TABLE>
